Navigation Links
Drug resistance testing in treatment-naive HIV patients is cost-effective

Testing for drug resistance in HIV-infected patients at the time of HIV diagnosis is cost-effective and may increase patients' life expectancy, according to an article in the Nov. 1 issue of Clinical Infectious Diseases, now available online.

Resistance to antiretroviral therapy, even in patients who have never received treatment, is a growing concern. However, genotype resistance testing, which involves looking for the presence of resistance genes, is not a standard procedure at the time a patient is diagnosed with HIV, probably due to lack of data on its benefits and its relatively high cost compared with other routine blood tests.

A cost-effectiveness analysis conducted by a group of Boston researchers indicates that performing genotype resistance testing at initial HIV diagnosis--before treatment is started--can effectively guide a physician's choice of treatment regimen and increase a patient's quality-adjusted life expectancy. (Quality-adjusted measurements of time reflect that survival with an illness is presumed to be of lower quality than healthy survival.)

"For the approximately 90 percent of patients with no resistance, the testing provides no benefit," said lead author Paul Sax, MD, of Brigham and Women's Hospital. "However, if certain types of resistance are present [when a patient is first diagnosed with HIV], our study projects a substantial increase in survival" of more than 14 months, compared with no resistance testing.

Resistance rates vary from place to place. It is estimated that, in the United States and Europe, the average resistance rate in treatment-naive patients is between 8 and 10 percent, although baseline resistance may be as high as 16 percent in gay men, "likely reflecting their overall greater access to treatment since the beginning of the epidemic," said Dr. Sax. Using a model with a resistance rate of just over 8 percent, the analysis estimated a cost of $23,900 per quality-adjusted life year gain
'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
2. Researchers make gains in understanding antibiotic resistance
3. MUHC scientists describe genetic resistance to rampant virus
4. New polysaccharide may help combat multidrug resistance in cancer
5. New book explains antibiotic resistance for a broad audience
6. Insects develop resistance to engineered crops
7. Retroviral resistance gene found
8. Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance
9. Gaining ground in the race against antibiotic resistance
10. Genes linked to treatment resistance in children with leukemia
11. Einstein researchers identify new way that bacteria develop resistance to antibiotics
Post Your Comments:
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... Bethesda, MDA combination of two techniques promises to ... while also reducing potential side effects says a new ... the FASEB Journal ( http://www.fasebj.org ). The ... involving the use of site-specific recombinases, or enzymes that ...
... and climatic zones move polewards, species will need to find ... the journal Molecular Ecology , has revealed that climate ... a range of new habitats. The study, led ... to understand the role of evolution in helping a species ...
... looks like bone. It feels like bone. For the most ... inkjet printer., Washington State University researchers have used a 3D ... be used in orthopedic procedures, dental work, and to deliver ... as a scaffold for new bone to grow on and ...
Cached Biology News:The newest of the new in gene therapy: 'Tag and target and exchange' 2British butterfly is evolving to respond to climate change 2
(Date:5/1/2015)... 2015 According to a ... (Equipment, Consumables), by Type (Monoclonal, Polyclonal), by Technology ... Institutes) - Analysis & Global Forecast to 2019", ... Antibody Production Market for the forecast period of ... reach $2.572 Billion by 2019 from $1.425 Billion ...
(Date:4/30/2015)... Blythewood, South Carolina (PRWEB) May 01, 2015 ... steam system services, is extremely proud to announce that ... have been named as a winner of a Queen’s ... business success for the design and manufacture of a ... is the revolutionary alternative to traditional steam flow ...
(Date:4/30/2015)... 2015   Tamir Biotechnology , a leading developer ... its Ebola antiviral therapy program. Clinical ... currently being evaluated and considered by a number of ... During the first quarter of 2015, the company participated ... The Evaluation of Potential Treatments and Vaccines For Ebola ...
(Date:4/30/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... it has commenced an underwritten public offering of its ... underwriters a 30-day option to purchase up to an ... offered in the public offering. The offering is subject ... as to whether or when the offering may be ...
Breaking Biology Technology:Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... PETERSBURG, Va., Jan. 6 Star Scientific (Nasdaq ... Pharmaceuticals, Inc., in conjunction with its Star Tobacco, ... the ability of Stonewall(R) dissolvable smokeless tobacco ... an over-the-counter nicotine replacement product (NRT). The study, ...
... Inc., a leading provider,of software and high quality ... analysis , today announced that Bayer Schering Pharma ... years. Bayer Schering Pharma,has programs for cancer, ... coverage of these diseases and others. GeneGo ...
... Way For Use of ALD Ultra High-k Insulators; Marks ... ST. LOUIS, Jan. 6 ASM International N.V. (Nasdaq: ... and SAFC Hitech(TM), a business segment within SAFC(R), a ... ), today announced that they have entered into a ...
Cached Biology Technology:Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 2Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 3Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation 4GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years 2ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement 2ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement 3ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement 4
... Clean and Accurate Results Laser Capture ... the sensitivity and accuracy of molecular assays ... types and multi-cellular structures isolated from whole ... to microdissection-developed in 1996 at the National ...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
... raised against a partial recombinant ... K6HF (NP_004684, 141 a.a. ... protein with GST tag. ... NM_004693 Protein ...
... DNA Visualizer DX's sensitivity of DNA detection ... DNA band in an agarose gel can be ... this kit can be purified by organic solvent ... tested commercially kits worked well.) DNA excised ...
Biology Products: